SymBio Pharmaceuticals Ltd. | Balance Sheet
Fiscal year is January-December. All values JPY Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
7,316
6,625
4,261
5,731
2,963
Total Accounts Receivable
33
293
301
522
588
Inventories
125
245
133
273
363
Other Current Assets
160
128
131
158
122
Total Current Assets
7,634
7,290
4,827
6,685
4,037
Net Property, Plant & Equipment
9
49
53
75
47
Total Investments and Advances
27
47
51
65
86
Intangible Assets
8
66
52
42
69
Total Assets
7,687
7,454
4,984
6,878
4,252
ST Debt & Current Portion LT Debt
1
1
1
-
-
Accounts Payable
-
306
320
322
604
Income Tax Payable
23
21
14
37
55
Other Current Liabilities
228
160
216
584
352
Total Current Liabilities
251
488
551
942
1,011
Long-Term Debt
1
1
-
450
-
Provision for Risks & Charges
2
2
2
1
1
Total Liabilities
254
490
552
1,394
1,013
Common Equity (Total)
7,433
6,964
4,432
5,485
3,239
Total Shareholders' Equity
7,433
6,964
4,432
5,485
3,239
Total Equity
7,433
6,964
4,432
5,485
3,239
Liabilities & Shareholders' Equity
7,687
7,454
4,984
6,878
4,252
About SymBio Pharmaceuticals
View Profile
